Alexandra E. Rätz Bravo

533 total citations
12 papers, 358 citations indexed

About

Alexandra E. Rätz Bravo is a scholar working on Pharmacology, Pharmacology and Toxicology. According to data from OpenAlex, Alexandra E. Rätz Bravo has authored 12 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Pharmacology and 3 papers in Toxicology. Recurrent topics in Alexandra E. Rätz Bravo's work include Drug-Induced Hepatotoxicity and Protection (4 papers), Drug-Induced Adverse Reactions (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Alexandra E. Rätz Bravo is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (4 papers), Drug-Induced Adverse Reactions (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Alexandra E. Rätz Bravo collaborates with scholars based in Switzerland and United States. Alexandra E. Rätz Bravo's co-authors include Stephan Krähenbühl, Evangelia Liakoni, Sabin S Egger, Stephan Krähenbühl, Manuel Haschke, Raymond G. Schlienger, Wolfgang Ummenhofer, Jürgen Drewe, Hans Pargger and Luigi Terracciano and has published in prestigious journals such as Critical Care Medicine, JAMA Internal Medicine and Drug Safety.

In The Last Decade

Alexandra E. Rätz Bravo

11 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra E. Rätz Bravo Switzerland 9 120 80 73 64 51 12 358
L. A. Garcia Rodriguez Spain 6 186 1.6× 105 1.3× 59 0.8× 41 0.6× 13 0.3× 6 496
Zul Verjee Canada 12 51 0.4× 24 0.3× 59 0.8× 20 0.3× 27 0.5× 22 448
A. Plaschke Germany 11 74 0.6× 22 0.3× 187 2.6× 90 1.4× 137 2.7× 15 744
Hoi Y. Tong Spain 12 86 0.7× 28 0.3× 34 0.5× 8 0.1× 31 0.6× 26 385
Esther Salgueiro Spain 10 85 0.7× 24 0.3× 45 0.6× 13 0.2× 8 0.2× 30 396
Claudia B. Karwoski United States 6 174 1.4× 8 0.1× 78 1.1× 72 1.1× 19 0.4× 6 408
David Hassman United States 11 23 0.2× 22 0.3× 70 1.0× 43 0.7× 30 0.6× 16 739
R. Hidalgo Brazil 10 95 0.8× 6 0.1× 76 1.0× 130 2.0× 42 0.8× 21 347
Ariola Koci Italy 10 60 0.5× 111 1.4× 37 0.5× 9 0.1× 4 0.1× 16 386
L. Connors United States 6 82 0.7× 81 1.0× 36 0.5× 17 0.3× 15 0.3× 7 476

Countries citing papers authored by Alexandra E. Rätz Bravo

Since Specialization
Citations

This map shows the geographic impact of Alexandra E. Rätz Bravo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra E. Rätz Bravo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra E. Rätz Bravo more than expected).

Fields of papers citing papers by Alexandra E. Rätz Bravo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra E. Rätz Bravo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra E. Rätz Bravo. The network helps show where Alexandra E. Rätz Bravo may publish in the future.

Co-authorship network of co-authors of Alexandra E. Rätz Bravo

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra E. Rätz Bravo. A scholar is included among the top collaborators of Alexandra E. Rätz Bravo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra E. Rätz Bravo. Alexandra E. Rätz Bravo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Bravo, Alexandra E. Rätz, et al.. (2019). Agranulozytose nach Metamizol-Reexposition und Cefepim-induzierte Enzephalopathie mit fatalem Ausgang. Praxis. 108(10). 693–697.
3.
Bravo, Alexandra E. Rätz, et al.. (2018). C-Reactive Protein and Procalcitonin in Case Reports of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. International Archives of Allergy and Immunology. 176(1). 44–54. 14 indexed citations
4.
Liakoni, Evangelia, Alexandra E. Rätz Bravo, & Stephan Krähenbühl. (2015). Hepatotoxicity of New Oral Anticoagulants (NOACs). Drug Safety. 38(8). 711–720. 49 indexed citations
5.
Liakoni, Evangelia, Alexandra E. Rätz Bravo, Luigi Terracciano, Markus H. Heim, & Stephan Krähenbühl. (2014). Symptomatic Hepatocellular Liver Injury With Hyperbilirubinemia in Two Patients Treated With Rivaroxaban. JAMA Internal Medicine. 174(10). 1683–1683. 33 indexed citations
6.
Haschke, Manuel, et al.. (2014). Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports. European Journal of Clinical Pharmacology. 71(2). 209–217. 67 indexed citations
7.
Egger, Sabin S, et al.. (2013). Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations. European Journal of Clinical Pharmacology. 69(8). 1565–1573. 42 indexed citations
8.
Meyer‐Massetti, Carla, et al.. (2011). Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case. International Journal of Clinical Pharmacy. 33(5). 806–814. 21 indexed citations
9.
Egger, Sabin S, et al.. (2011). Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis. European Journal of Clinical Pharmacology. 68(2). 179–188. 53 indexed citations
10.
Bodmer, Mark, Manuel Haschke, Alexandra E. Rätz Bravo, & Matthias E. Liechti. (2009). Nierenversagen und hämolytische Anämie. Praxis. 98(4). 179–185. 2 indexed citations
11.
Bravo, Alexandra E. Rätz, Jürgen Drewe, Raymond G. Schlienger, et al.. (2005). Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature*. Critical Care Medicine. 33(1). 128–134. 61 indexed citations
12.
Bravo, Alexandra E. Rätz, et al.. (2004). Lithium Intoxication as a Result of an Interaction with Rofecoxib. Annals of Pharmacotherapy. 38(7-8). 1189–1193. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. A. Garcia Rodriguez Breakdown of academic impact, for papers by Zul Verjee Breakdown of academic impact, for papers by A. Plaschke Breakdown of academic impact, for papers by Hoi Y. Tong Breakdown of academic impact, for papers by Esther Salgueiro Breakdown of academic impact, for papers by Claudia B. Karwoski Breakdown of academic impact, for papers by David Hassman Breakdown of academic impact, for papers by R. Hidalgo Breakdown of academic impact, for papers by Ariola Koci Breakdown of academic impact, for papers by L. Connors
Rankless by CCL
2026